Home » Stocks » 22nd Century Group

22nd Century Group, Inc. (XXII)

Stock Price: $0.737 USD -0.016 (-2.11%)
Updated Jul 2, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 102.36M
Revenue (ttm) 26.60M
Net Income (ttm) -28.51M
Shares Out 138.85M
EPS (ttm) -0.22
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 2, 2020
Last Price $0.737
Previous Close $0.753
Change ($) -0.016
Change (%) -2.11%
Day's Open 0.750
Day's Range 0.735 - 0.770
Day's Volume 818,029
52-Week Range 0.600 - 2.460

More Stats

Market Cap 102.36M
Enterprise Value 69.98M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 138.85M
Float 138.13M
EPS (basic) -0.22
EPS (diluted) -0.22
FCF / Share -0.11
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 12.74M
Short Ratio 14.15
Short % of Float 10.26%
Beta 1.27
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 3.85
PB Ratio 1.89
Revenue 26.60M
Operating Income -24.13M
Net Income -28.51M
Free Cash Flow -14.98M
Net Cash 32.38M
Net Cash / Share 0.23
Gross Margin 0.05%
Operating Margin -90.74%
Profit Margin -107.20%
FCF Margin -56.31%
ROA -18.03%
ROE -44.51%
ROIC -53.70%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$11.50*
Low
11.5
Current: 0.737
High
11.5
Target: 11.50
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue25.8326.4316.6012.288.520.537.280.021.010.05
Revenue Growth-2.25%59.19%35.18%44.1%1510.99%-92.73%38666.35%-98.15%1933.06%-
Gross Profit0.010.90-0.71-0.43-0.580.036.82-0.050.590.02
Operating Income-25.37-24.02-13.30-11.39-12.04-10.591.81-3.24-3.76-1.10
Net Income-26.56-7.97-13.03-11.58-11.03-15.60-26.15-6.74-1.35-1.42
Shares Outstanding12612410179.8468.1459.9943.6430.4226.3912.44
Earnings Per Share-0.21-0.06-0.13-0.15-0.16-0.26-0.60-0.22-0.05-0.11
Operating Cash Flow-14.59-17.84-12.07-9.89-7.32-6.583.86-1.76-3.45-0.91
Capital Expenditures-0.36-0.45-1.16-0.20-0.040.42-3.45--0.01-
Free Cash Flow-14.95-18.29-13.23-10.08-7.36-6.160.40-1.76-3.46-0.91
Cash & Equivalents38.9656.3562.6413.473.766.405.830.000.250.00
Total Debt1.481.54-0.310.621.100.172.691.421.34
Net Cash / Debt37.4954.8262.6413.163.145.305.66-2.69-1.17-1.33
Assets68.9577.3079.7427.6418.3721.9512.292.642.392.80
Liabilities6.906.024.313.316.646.734.768.783.604.89
Book Value62.0571.2875.4324.3311.7315.227.52-6.13-1.22-2.09
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name 22nd Century Group, Inc.
Country United States
Employees 67
CEO James A Mish

Stock Information

Ticker Symbol XXII
Stock Exchange NYSE American
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Unique Identifier NYSEAMERICAN: XXII

Description

22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM research cigarettes for use in independent clinical studies. The company's products under development include BRAND A, a very low nicotine content cigarette; X-22, a tobacco-based botanical medical product for use as an aid to smoking cessation; and BRAND B, a low-tar-to-nicotine ratio cigarette. It is also involved in contract manufacturing business for third-party branded tobacco products. The company has a strategic research and development agreement with Keygene N.V. to develop hemp/cannabis plants for medical and therapeutic use, and other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.